What Researchers Did
Researchers conducted a review of current evidence-based literature to evaluate the use of hyperbaric oxygen therapy (HBOT) in acute thermal injury and carbon monoxide intoxication.
What They Found
The review found that despite observed benefits in animal models and a few randomized controlled trials, there is insufficient evidence to routinely support or disprove the use of hyperbaric oxygen therapy (HBOT) in burn care. An ongoing controversy exists regarding HBOT's use, indications, and cost-effectiveness, and its efficiency remains largely unknown to many physicians.
What This Means for Canadian Patients
For Canadian patients with burns, hyperbaric oxygen therapy (HBOT) is not currently a routinely recommended treatment due to a lack of sufficient evidence supporting its widespread use. Patients should discuss all treatment options with their healthcare providers, understanding that more research is needed to determine the definitive role of HBOT in burn care.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The primary limitation of this review is the insufficient quantity of high-quality, large-scale randomized controlled trials available to definitively evaluate hyperbaric oxygen therapy in burn treatment.